The battle of the “heartbreak of psoriasis”, my trial is better than yours! BD A new Johnson & Johnson drug trial has put Amgen on the defensive. According to the 903-patient study, J&J's experimental drug ustekinumab (Stelara) proved more effective at treating psoriasis than...
Helpful news for the former employees of Amgen, they get an extension on paying off a 2nd mortgage, but some feel this will help, but still not perhaps save the boat. Pharma layoffs in recent years have primarily been in the area of sales and marketing; however now with mergers, acquisitions...
All over healthcare the big fish, little fish story is either taking place or actions are in the making for offers. There certainly are a number of big Pharma companies with money to foot the bill, that is if the Biotech companies see it fit to consider the options. One problem as indicated in...